Antihypertensive efficacy and adherence to treatment with the fixed-dose combination therapy in ambulatory patients aged 50-65 years with uncontrolled arterial hypertension
- Authors: Larina V.N.1, Orlov D.A.1, Sviridova I.V.1
-
Affiliations:
- Pirogov Russian National Research Medical University
- Issue: Vol 21, No 5 (2019)
- Pages: 19-26
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/96795
- DOI: https://doi.org/10.26442/20751753.2019.5.190350
- ID: 96795
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Vera N. Larina
Pirogov Russian National Research Medical University
Email: larinav@mail.ru
D. Sci. (Med.) Moscow, Russia
Denis A. Orlov
Pirogov Russian National Research Medical UniversityGraduate Student Moscow, Russia
Irina V. Sviridova
Pirogov Russian National Research Medical UniversityCand. Sci. (Med.) Moscow, Russia
References
- GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019. DOI: 10.1016/ S1474-4422(19)30034-1
- Самородская И.В., Андреев Е.М., Заратьянц О.В. и др. Показатели смертности населения старше 50 лет от цереброваскулярных болезней за 15-летний период в России и США. Неврология, нейропсихиатрия, психосоматика. 2017; 9 (2): 15-24. @@Samorodskaia I.V., Andreev E.M., Zarat'iants O.V. i dr. Pokazateli smertnosti naseleniia starshe 50 let ot tserebrovaskuliarnykh boleznei za 15-letnii period v Rossii i SShA. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2017; 9 (2): 15-24
- Shah R, Wilkins E, Nichols M et al. Epidemiology report: trends in sex-specific cerebrovascular diseasemortality in Europe based on WHO mortality data. Eur Heart J 2019; 40: 755-64. doi: 10.1093/eurheartj/ehy378.
- Бадин Ю.В., Фомин И.В., Беленков Ю.Н. и др. ЭПОХА-АГ 1998-2017 гг.: динамика распространенности, информированности об артериальной гипертонии, охвате терапией и эффективного контроля артериального давления в Европейской части РФ. Кардиология. 2019; 59 (1S): 34-42. doi: 10.18087/cardio.2445 @@Badin Iu.V., Fomin I.V., Belenkov Iu.N. i dr. EPOKhA-AG 1998-2017 gg.: dinamika rasprostranennosti, informirovannosti ob arterial'noi gipertonii, okhvate terapiei i effektivnogo kontrolia arterial'nogo davleniia v Evropeiskoi chasti RF. Kardiologiia. 2019; 59 (1S): 34-42. doi: 10.18087/cardio.2445
- Wilkins E, Wilson L, Wickramasinghe K et al. European Cardiovascular Disease Statistics 2017. Brussels: Eur Heart Network, 2017.
- Williams B, Mancia G, Spiering W et al. ESC Scientific Document Group; 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39 (33): 3021-104.
- https://www.rand.org/health/surveys_tools/mos/36-item-short-form.html.
- Morisky D.E, Green L.W, Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (1): 67-74.
- Mills K.T, Bundy J.D, Kelly T.N et al. Global disparities of hypertension prevalence and control: a systematic analysis of populationbased studies from 90 countries. Circulation 2016; 134: 441-50.
- Шальнова С.А., Драпкина О.М. Тренды смертности от болезней системы кровообращения и злокачественных новообразований у российских мужчин и женщин в 2000-2016 гг. Рациональная фармакотерапия в кардиологии. 2019; 15 (1): 77-83. doi: 10.20996/1819-6446-2019-15-1-77-83 @@Shal'nova S.A., Drapkina O.M. Trendy smertnosti ot boleznei sistemy krovoobrashcheniia i zlokachestvennykh novoobrazovanii u rossiiskikh muzhchin i zhenshchin v 2000-2016 gg. Ratsional'naia farmakoterapiia v kardiologii. 2019; 15 (1): 77-83. doi: 10.20996/1819-6446-2019-15-1-77-83
- Шальнова С.А., Капустина А.В., Деев А.Д., Баланова Ю.А. Факторы, ассоциированные с основными причинами смерти в России. Данные многолетнего проспективного исследования 1977-2001 гг. Рациональная фармакотерапия в кардиологии. 2019; 15 (1): 4-16. doi: 10.20996/1819-6446-2019-15-1-4-16 @@Shal'nova S.A., Kapustina A.V., Deev A.D., Balanova Iu.A. Faktory, assotsiirovannye s osnovnymi prichinami smerti v Rossii. Dannye mnogoletnego prospektivnogo issledovaniia 1977-2001 gg. Ratsional'naia farmakoterapiia v kardiologii. 2019; 15 (1): 4-16. doi: 10.20996/1819-6446-2019-15-1-4-16
- Kishore S, Salam A, Rodgers A et al. Fixed-dose combinations for hypertension. Lancet 2018; 392: 819-20. doi: 10.1016/S0140-6736(18)31814-2
- Williams B, Mancia G, Spiering W et al. Authors/Task Force Members. 2018 ESC/ ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens 2018; 36 (10): 1953-2041.
- Bronsert M, Henderson W, Valuck R et al. Comparative effectiveness of antihyperthensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) study. J Am Board Fam Med 2013; 26: 529-38.
- Parati G, Stergiou G, O'Brien E et al. European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014; 32: 1359-66.
- Ernst G, Bosio M, Salvado A. с Difference between apnea-hypopnea index (AHI) and oxygen desaturation index (ODI): proportional increase associated with degree of obesity. Sleep Breath 2016; 4 (20): 1175-83.
- Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization, 2003.
- Shin S, Song H, Oh S et al. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2013; 36 (11): 1000-5.
- Baggarly A, Kemp R, Wang X, Magoun A. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population. Res Soc Administrative Pharm 2014; 10: e99-e112.
- Bloom B. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20: 671-81.
- Глезер М.Г., Сайгитов Р.Т. Эффективность лечения артериальной гипертонии индапамидом замедленного высвобождения у мужчин и женщин в зависимости от наличия сахарного диабета 2-го типа. Результаты программы БОЛЕРО. Проблемы женского здоровья 2008; 3 (4): 5-13. @@Glezer M.G., Saigitov R.T. Effektivnost' lecheniia arterial'noi gipertonii indapamidom zamedlennogo vysvobozhdeniia u muzhchin i zhenshchin v zavisimosti ot nalichiia sakharnogo diabeta 2-go tipa. Rezul'taty programmy BOLERO. Problemy zhenskogo zdorov'ia 2008; 3 (4): 5-13.
- Kawalec P, Holko P, Gawin M, Pilc A. Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis. Arch Med Sci 2018; 14 (5): 1125-36. doi: 10.5114/aoms.2018.77561
- Kumagai N, Onishi K, Hoshino K et al. Improving drug adherence using fixed combinations caused beneficial treatment outcomes and decreased health-care costs in patients with hypertension. Clin Exp Hypertens 2013; 35: 355-60.
- Nedogoda S, Stojanov V. Single-Pill Combination of Perindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension: A Randomized Controlled Trial. Cardiol Ther 2017; 6 (1): 91-104. doi: 10.1007/s40119-017-0085-7
- Landolfo M, Borghi C. Hyperuricaemia and vascular risk: the debate continues. Curr Opin Cardiol 2019; Mar 28. doi: 10.1097/HCO.0000000000000626
Supplementary files
